🇺🇸 FDA
Pipeline program

Budesonide-Surfactant

DMR92-IRB-127

Approved small_molecule terminated

Quick answer

Budesonide-Surfactant for Premature Infants is a Approved program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Premature Infants
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials